Target- |
MechanismThrombin replacements |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date03 Feb 1986 |
100 Clinical Results associated with GenTrac, Inc.
0 Patents (Medical) associated with GenTrac, Inc.
100 Deals associated with GenTrac, Inc.
100 Translational Medicine associated with GenTrac, Inc.